Klingström J

Family name	Klingström
Given name	Jonas
Initials	J
ORCID	ORCID 0000-0001-9076-1441
Affiliations	Center för Infectious Medicine Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden. Department of Microbiology Public Health Agency of Sweden Solna Sweden.

19 publications

PubMed DOI Crossref

Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional Anomalies

Kammann T, Gorin JB, Parrot T, ..., Strålin K, Sandberg JK

The Journal of Immunology 212 (3) 389-396 [2024-02-01; online 2023-12-20]

Category: Serology Type: Journal article

PubMed DOI Crossref

Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.

Bladh O, Greilert-Norin N, Havervall S, ..., Klingström J, Thålin C

N Engl J Med 389 (17) 1626-1628 [2023-10-26; online 2023-10-27]

Category: Biochemistry Category: Genomics & transcriptomics Category: Health Funder: KAW/SciLifeLab Type: Journal article

PubMed DOI Crossref

Comprehensive proteomics and meta-analysis of COVID-19 host response.

Babačić H, Christ W, Araújo JE, ..., Klingström J, Pernemalm M

Nat Commun 14 (1) 5921 [2023-09-22; online 2023-09-22]

Category: Other Category: Proteins Funder: KAW/SciLifeLab Funder: VR Type: Journal article

PubMed DOI Crossref

Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19.

Yu M, Charles A, Cagigi A, ..., Loré K, Smed-Sörensen A

Nat Commun 14 (1) 2164 [2023-04-15; online 2023-04-15]

Category: Biochemistry Category: Health Type: Journal article

Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers

Marking U, Havervall S, Norin NG, ..., Klingström J, Thålin C

Nat Commun 14 (1) - [2023-03-22; online 2023-03-22] Open Access

Open Access

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Type: Journal article

PubMed DOI Crossref

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection.

Havervall S, Marking U, Svensson J, ..., Smed-Sörensen A, Thålin C

N Engl J Med 387 (14) 1333-1336 [2022-10-06; online 2022-09-14]

Category: Biochemistry Category: Health Category: Omicron VoC Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Type: Journal article

PubMed DOI Crossref

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.

Monteil V, Eaton B, Postnikova E, ..., Wirnsberger G, Penninger JM

EMBO Mol Med 14 (8) e15230 [2022-08-08; online 2022-07-04]

Category: Biochemistry Category: Health Type: Journal article

PubMed DOI Crossref

Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines.

Marking U, Havervall S, Greilert-Norin N, ..., Åberg M, Thålin C

Vaccines 10 (3) 359 [2022-02-24; online 2022-02-24]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Type: Journal article

PubMed DOI Crossref

Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.

Kaku CI, Champney ER, Normark J, ..., Forsell MNE, Walker LM

Science - (-) eabn2688 [2022-02-10; online 2022-02-10]

Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab Type: Journal article

PubMed DOI Crossref

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection

Havervall S, Jernbom Falk A, Klingström J, ..., Nilsson P, Thålin C

PLoS One 17 (1) e0262169 [2022-01-12; online 2022-01-12] Open Access

Open Access

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Funder: VR Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article

Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time

Havervall S, Marking U, Greilert‐Norin N, ..., Åberg M, Thålin C

Clin Transl Immunol 11 (4) - [2022-01-00; online 2022-04-18] Open Access

Open Access

Category: Biochemistry Category: Health Category: Vaccines Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Type: Journal article

PubMed DOI Crossref

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C

J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27] Open Access

Open Access

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution

PubMed DOI Crossref

High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.

Lourda M, Dzidic M, Hertwig L, ..., Chambers BJ, Karolinska KI/K COVID-19 Study Group

Proc Natl Acad Sci U S A 118 (40) - [2021-10-05; online 2021-09-23] Open Access

Open Access

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Funder: VR Type: Journal article

PubMed DOI Crossref

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination

Normark J, Vikström L, Gwon YD, ..., Ahlm C, Forsell M

N Engl J Med 385 (11) 1049-1051 [2021-09-09; online 2021-09-09] Open Access

Open Access

Category: Biochemistry Category: Drug Discovery Category: Vaccines Funder: KAW/SciLifeLab Funder: VR Research Area: Vaccine Type: Journal article

PubMed DOI Crossref

Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2.

Havervall S, Marking U, Greilert-Norin N, ..., Åberg M, Thålin C

EBioMedicine 70 (-) 103523 [2021-08-00; online 2021-08-12] Open Access

Open Access

Category: Drug Discovery Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article

PubMed DOI Crossref

Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.

Hober S, Hellström C, Olofsson J, ..., Hedhammar M, Nilsson P

Clin Transl Immunol 10 (7) e1312 [2021-07-19; online 2021-07-19] Open Access

Open Access

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Research Area: Biobanks for COVID-19 research Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Type: Journal article

PubMed DOI Crossref

SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.

Sandberg JT, Varnaitė R, Christ W, ..., Gredmark-Russ S, Karolinska COVID‐19 Study Group

Clin Transl Immunol 10 (7) e1306 [2021-07-05; online 2021-07-05] Open Access

Open Access

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab Research Area: Host cell systems biology and targets Type: Journal article

PubMed DOI Crossref

Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.

Varnaitė R, García M, Glans H, ..., Klingström J, Gredmark-Russ S

J Immunol 205 (9) 2437-2446 [2020-11-01; online 2020-09-02]

Category: Biochemistry Category: Health Category: Proteins Funder: KAW/SciLifeLab Funder: VR Research Area: Host cell systems biology and targets Type: Journal article

SciLifeLab Data Centre

Publications 9.5.0